Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

ClinicalTrials.gov ID: NCT01276639

Public ClinicalTrials.gov record NCT01276639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy And Safety Of 2 Oral Doses Of CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Study identification

NCT ID
NCT01276639
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
901 participants

Conditions and interventions

Conditions

Interventions

  • CP-690,550 Drug
  • Placebo/CP-690,550 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Mar 31, 2013
Completion
Mar 31, 2013
Last update posted
Sep 18, 2014

2011 – 2013

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
28
Facility City State ZIP Site status
Radiant Research, Inc. Birmingham Alabama 35209
University of California, Irvine - Dermatology Research Irvine California 92697
Skin Surgery Medical Group, Inc. San Diego California 92117
Clinical Science Institute Santa Monica California 90404
Cherry Creek Research, Inc. Denver Colorado 80209
The Savin Center, P.C. New Haven Connecticut 06511
Renstar Medical Research Ocala Florida 34471
Academic Alliance in Dermatology Tampa Florida 33609
Atlanta Dermatology, Vein & Research Center, P.C. Alpharetta Georgia 30022
Peachtree Dermatology Associates Research Center Atlanta Georgia 30327
MedaPhase Inc. Newnan Georgia 30263
Southern Illinois University School of Medicine Springfield Illinois 62702
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital - Clinical Unit for Research Trials and Outcomes in Skin Boston Massachusetts 02114
Skin Specialists, P.C. Omaha Nebraska 68144
New York University School of Medicine New York New York 10016
Skin Search of Rochester, Inc. Rochester New York 14623
Raleigh Radiology Blue Ridge Raleigh North Carolina 27612
Wake Research Associates Raleigh North Carolina 27612
Central Sooner Research Norman Oklahoma 73071
Baker Allergy, Asthma and Dermatology Research Center, LLC Lake Oswego Oregon 97035
University of Pittsburgh Medical Center - Department of Dermatology Pittsburgh Pennsylvania 15213
Clinical Partners, LLC Johnston Rhode Island 02919
Dermatology Associates of Knoxville, PC Knoxville Tennessee 37917
Modern Research Associates, PLLC Dallas Texas 75231
Menter Dermatology Research Institute Dallas Texas 75246
Center for Clinical Studies Houston Texas 77030
Rockwood Dermatology Center Spokane Washington 99202
Rockwood Research Center Spokane Washington 99202
Wenatchee Valley Medical Center - Clinical Research Department Wenatchee Washington 98801
Madison Skin and Research, Inc. Madison Wisconsin 53719

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01276639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01276639 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →